The biggest modern breakthrough for cancer treatment has been antibody therapies. An increasing number of biotechnology companies have antibody - or vaccine-based cancer therapies in development. This course aims to attract students interested in tumour immunology who wish to pursue a career either in industry (biotechnology) or academia.
The course covers both antibody and vaccine cancer therapies and explores the immunology of the tumour host interface. In addition, students will learn about intellectual property and how to exploit scientific research in scientific writings, patents and in development of business plans applicable to the biotechnology industry. To gain practical experience in research students will carry out a research project in the field of tumour immunology.
Aims and objectives
- Acquire a specialised knowledge in tumour immunology with particular reference to monoclonal antibody and cancer vaccines - Develop the critical and analytical power to evaluate scientific literature - Perform a scientific research project - Acquire the ability to communicate scientific results orally and in writing - Learn about business exploitation of cancer therapy
Innovative features of the course
- The only MSc course based entirely on tumour immunology - Students undertake a substantial research project, during which time they acquire a considerable amount of laboratory-based skills - A module based entirely on scientific writing and the development of a business plan - Individuals from industry lecture on the course - It is suitable for graduates in Life Sciences, Biomedical Sciences and allied subjects and also for people already in suitable employment who wish to improve and update their knowledge and experience - It attracts students from the UK and worldwide
"I really enjoyed the course. At first I thought it might be too much of a challenge for me to catch up with everyone because I did not do much molecular science, but the lecturers and staff were really helpful. They made sure everyone was on the same level and there was always someone with whom you could speak if you had any problems. Let's just say they are always there if you need help.
The course also focused on the business side as well, which was a nice change. We were also given lectures by people from the industry. All in all, I would have no hesitation in recommending this course to anyone seeking to develop their scientific knowledge, skills and enhance their career prospects."
"The course prepared me for the cut-throat business of securing research funding, patents and the enormous opportunities available in this new and fascinating field.
Nottingham is a wonderful place to study with excellent academic support and several postgraduate social events throughout the year. I thoroughly enjoyed my one year here."
Comments from potential employers (biotechnology companies)
"This subject is currently undergoing massive expansion and yet qualified graduates are difficult to find. The industry as a whole would benefit from having a source of students with this qualification and from our point of view, such a course may provide candidates that are potentially useful to our company."
"A course in cancer immunotherapy would provide valuable training for people wanting to seek a career in the biopharmaceutical industry where much of the research and development effort is focussed on targeted biological therapies for cancer."